Aug 2026· Schizophrenia Research· Vol 297, pp.
182-190
· 0 citations· 61 references
Medicine
TL;DR
Subregional differences within the midbrain, with no change in the VTA, are demonstrated, and the substantia nigra undergoes the prominent molecular changes in Schizophrenia are provided, providing insight into the spatial molecular pathology of the midbrain in schizophrenia.
Abstract
Schizophrenia is a chronic psychiatric disorder affecting 1% of the population. Common treatment strategies include antipsychotics that block or modulate dopamine receptors. However, ∼34% of patients exhibit resistance to current antipsychotic medications targeting dopaminergic receptors, which are central to the pathophysiology of psychosis. Consequently, research has focused on alternative modulators of dopamine signaling. The cannabinoid receptor 1 (CB1) has the potential to neuromodulate neurons. CB1 expression in dopamine neurons and reactive GFAP+ astrocytes is altered in schizophrenia. Here, we examined CB1 expressions in dopamine neurons and reactive GFAP+ astrocytes using immunofluorescent staining in post-mortem human midbrain tissue from individuals with schizophrenia (n = 9) and matched controls (n = 10). As previously established, within the substantia nigra we report no change in dopamine neurons and increased number of astrocytes. No changes were found in the ventral tegmental area (VTA). Upon subregional analysis of the substantia nigra, there was decreased CB1 expression on dopamine neurons in the medial and ventral subregions of the substantia nigra. Notably, astrocyte density increased specifically in the dorsal subregion, with no change in astrocytic CB1. These findings demonstrate subregional differences within the midbrain, with no change in the VTA, and that the substantia nigra undergoes the prominent molecular changes in Schizophrenia. Overall, it provides insight into the spatial molecular pathology of the midbrain in schizophrenia.
A reorganization of molecular networks in schizophrenia is demonstrated, with alterations in the micro-architecture of molecular couplings, strengthening the importance of investigating functional interactions among molecules, as such analyses may reveal significant alterations in schizophrenia that cannot be detected...
G. De Simone, T. Nuzzo, A. di Maio et al.· International Journal of Neu...· 0 citations
It is demonstrated that Ddit4 overexpression specifically in neurons is sufficient to reduce spine density in the PFC, impair temporal order memory, and induce transcriptional changes associated with stress and depression.
Alexander M. Kuhn, Kelly E. Bosis, Madeline M. Mairose et al.· eNeuro· 0 citations
It is suggested that cuprizone-induced intoxication disrupts VTA-mPFC circuitry, leading to mesocortical dopamine hypofunction, altered cortical plasticity, and executive dysfunction, and support targeting mesocortical dopamine transmission as a potential strategy for MS-related cognitive symptoms.
Laura Dazzi, G. Talani, F. Biggio et al.· Neurobiology of Disease· 0 citations
Abstract Background In humans, the D-neuron system in nucleus accumbens (D16), projection field of mesolimbic dopamine (DA) system, is far developed than in other animal species. "D-cell hypothesis of schizophrenia" (Ikemoto K., Lancet, 2025) has shown the lack of D-neurons in the D16 of post-mortem brains of schizophr...
K. Ikemoto· International Journal of Neu...· 0 citations
This work proposes a two-dimensional clinical framework for negative symptoms to better understand their neurobiological mechanism, by segregating symptoms into diminished expressivity and amotivation domains and explores how biological sex serves as a critical factor of individual variability in symptom expression.
D. Uliana, Anthony A. Grace· Schizophrenia Research· 0 citations
It is indicated that stereochemical and subunit-selective modulation of GABAA receptors critically determines circuit-level outcomes following stress and reinforce α5-GABAA receptors as a key target for normalizing hippocampal-driven dopamine system dysfunction associated with psychosis-relevant states.
Kayla Lilly, Prithu Mondal, James M. Cook et al.· Psychopharmacology· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.